AGA and aspartylglucosaminuria: Codon optimization of aspartylglucosaminidase (AGA) led to a 2.5 to 5-fold increase in expression in HEK293 and HeLa cells, supporting its utility for enzyme replacement therapy and gene therapy in aspartylglucosaminuria [43].